Clinical review report: AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.)
The objective of this document is to perform a systematic review of the beneficial and harmful effects of abobotulinumtoxinA (Dysport Therapeutic) for the treatment of cervical dystonia (CD) (spasmodic torticollis) in adults
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, August 2017
|
| Series: | CADTH common drug review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this document is to perform a systematic review of the beneficial and harmful effects of abobotulinumtoxinA (Dysport Therapeutic) for the treatment of cervical dystonia (CD) (spasmodic torticollis) in adults |
|---|---|
| Item Description: | "Version: Final." |
| Physical Description: | 1 PDF file (88 pages) illustrations |